SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.24 |
| Enterprise Value ($M) | 3.14 |
| Book Value ($M) | 9.59 |
| Book Value / Share | 3.55 |
| Price / Book | 0.34 |
| NCAV ($M) | 4.85 |
| NCAV / Share | 1.79 |
| Price / NCAV | 0.67 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.52 |
| Return on Equity (ROE) | -0.76 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.63 |
| Current Ratio | 4.10 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.45 |
| Assets | 11.18 |
| Liabilities | 1.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.88 |
| Operating Income | -5.77 |
| Net Income | -5.12 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -5.89 |
| Cash from Investing | -1.11 |
| Cash from Financing | 5.50 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | YA II PN, Ltd. |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,458 | 51,013 | 2.86 | |
| 25,947 | 106,538 | 24.35 | |
| 21,123 | 111,044 | 19.02 | |
| 24,155 | 100,297 | 24.08 | |
| 7,042 | 35,456 | 19.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SNPX – Synaptogenix, Inc. | SNTI – Senti Biosciences, Inc. |
| SONN – Sonnet BioTherapeutics Holdings, Inc. | SRZN – Surrozen, Inc. |
| SXTC – China SXT Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io